HIV Prevention Decision Tool for Young Adults
Part of Infections clinical trials.
This study tests a simple online tool to help young people decide whether PrEP (a daily pill that prevents HIV) might be right for them. The tool uses information from an at-home HIV test and is designed to make PrEP information easier to understand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 39 years old
- Be comfortable reading and speaking English
- Have internet access to use the online tool
- Be HIV negative (based on your self-report or test result)
- Have never taken PrEP before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This study compares different ways to help young men learn about and choose PrEP, a medicine that prevents HIV. It aims to see which approach works best for starting and staying on PrEP.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
This study tests a decision-support tool that helps people decide whether to use PrEP, a daily pill that prevents HIV, and helps clinics support that choice. It is for young adults in Alabama and Botswana, as well as clinic staff and policy makers, and aims to make it easier to start and stay on PrEP.
This study is testing a decision-support tool that helps emergency department patients learn about and start taking PrEP, a daily medicine that prevents HIV. If you are HIV negative and visiting the ER for a non-life-threatening issue, this study may help you access HIV prevention.
Hear when a new Pre-Exposure Prophylaxis (PrEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.